Journal Guide

* Biological Abstracts® (Thomson ISI) * BIOSIS Previews® (Thomson ISI) * Chemical Abstracts Service (CAS) * EMBASE (Elsevier) * Google Scholar * Index Copernicus (IC) * Index Medicus/MEDLINE/PubMed (NLM) * Journal Citation Reports (JCR) Science Edition (Thomson ISI) * Science Citation Index Expanded® (Thomson ISI) * Scopus (Elsevier).

Molecular Neurodegeneration is ready to receive manuscripts on all aspects of neurodegeneration research at the molecular and cellular levels.

Molecular Oncology highlights new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven translational research. Topics include:• Key biological processes such as cell cycle; DNA repair; apoptosis; invasion and metastasis; angiogenesis and lymphangiogenesis; cell signalling and interactive networks; immune response.• Emerging technologies (genomics, proteomics, functional genomics, metabolomics, tissue arrays, imaging), and model systems.•Biomarkers: diagnosis, prognosis, stratification and efficacy.• Cancer genetics, epigenetics, and genomic instability.• Minimal residual disease, pre-malignant lesions.• Cancer micro-environment.• Molecular pathology.• Tumour immunology.• Translational research.• Cancer therapy (target discovery, drug design, immunotherapy, combination therapies, resistance, and individualised treatment).• Chemotherapy, radiotherapy and surgery.• Clinical pharmacology.• Clinical trials, integration of basic science into cancer clinical trials.• Epidemiology and prevention.• Infrastructures (biobanks, databases, genomic resources).A main feature of the Journal is to provide an international forum for debating cancer issues, and for integrating the input of all the stakeholders.Coverage: Reviews, original articles, technical notes, editorials, news & views (commentary, science policy issues, ethical and legal issues, patient organisations, industry needs and alliances, regulatory issues, news items), letters to the editor, conference announcements, advertisements.Submitting Authors:Manuscripts can be submitted to Molecular Oncology at:http://ees.elsevier.com/molonc/

molecular oral microbiology publishes high quality research papers and reviews on fundamental or applied molecular studies of microorganisms of the oral cavity and respiratory tract, host-microbe interactions, cellular microbiology, molecular ecology, and immunological studies of oral and respiratory tract infections.Papers describing work in virology, or in immunology unrelated to microbial colonization or infection, will not be acceptable.

Molecular Pain is ready to receive manuscripts on all aspects of pain research at the cellular, subcellular and molecular levels. Molecular Pain is sponsored by the University of Cincinnati College of Medicine.

MPMI has instituted a feature called First Look. Within a few days of acceptance, papers by authors who choose to participate will be posted online. The papers have been peer reviewed and then revised as necessary by the authors but have not been copyedited, formatted, or assigned to an issue.The date on which each paper is posted is considered the publication date. The papers are fully citable by doi.The following statement appears on papers posted in First Look:MPMI "First Look" paper • doi: 10.1094/MPMI-00-00-0000 • posted 00/00/201XThis paper has been peer reviewed and accepted for publication but has not yetbeen copyedited or proofread. The final published version may differ.

Molecular Psychiatry publishes work aimed at elucidating biological mechanisms underlying psychiatric disorders and their treatment. The emphasis is on studies at the interface of pre-clinical and clinical research, including studies at the cellular, molecular, integrative, clinical, imaging and psychopharmacology levels.

Molecular Syndromology publishes high-quality research articles, short reports, and reviews on common and rare genetic syndromes, aiming to increase clinical understanding through molecular insights. Topics of particular interest are the molecular basis of genetic syndromes, genotype-phenotype correlation, natural history, strategies in disease management and novel therapeutic approaches based on molecular findings. Research on model systems is also welcome, especially when it is obviously relevant to human genetics. With high-quality reviews on current topics, the journal aims to facilitate translation of research findings to a clinical setting while also stimulating further research on clinically relevant questions. The journal targets not only medical geneticists and basic biomedical researchers, but also clinicians dealing with genetic syndromes. With 4 associate editors from 3 continents and a broad international editorial board, the journal welcomes submissions covering the lates

Molecular systems biology is an integrative discipline that seeks to explain the properties and behaviour of complex biological systems in terms of their molecular components and their interactions.Molecular Systems Biology is a peer-reviewed author-pays online journal that publishes full-length papers and accompanying synopses describing original research in the field of molecular systems biology and which focuses on the analysis, integration and modeling of molecular and cellular phenomena. Since molecular systems biology relies on a variety of computational and high-throughput technologies, the journal makes full use of the online to allow reader interaction with data and models presented in the published articles.Topics falling within the scope of the journal include, but are not limited to:* Proteomics* Metabolomics* Functional genomics* Structural genomics* Transcriptomics* Computational biology* Bioinformatics* Theoretical biology* Synthetic biologyMolecular Systems Biology aims to provide:The most integrative coverage: Molecular Systems Biology facilitates the integration of the individual subject areas that make up the overall field of molecular systems biology by ensuring that all research papers are accessible to all readers. This is done in three main ways:* All papers have a brief 'synopsis', which explains the findings and significance of the research. These will be written by the authors, with help from in-house editorial staff* Many papers are covered by News and Views articles. These are written by experts in the field and aim to place the research in a broader context* Rich linking from papers allows readers access to related databases and other web resourcesA forum for setting standards: The world-class Senior Editors and editorial board of Molecular Systems Biology will enable the journal to become a forum for the publication of papers that set the standards in this emerging field. Papers that aim to do this will be given special consideration, and readers will be encouraged to comment on the journal's 'feedback forum'.Unparalleled editorial support: No other journal in the field of systems biology offers the same level of editorial support as Molecular Systems Biology. Our in-house PhD-qualified editorial staff will work with the authors of all research papers to ensure that the synopses and manuscripts are as accessible and readable as possible, and they will commission accompanying 'News & Views' and review articles.The latest technological developments: Molecular Systems Biology is first journal from the Nature Publishing Group stable to accept data in the systems biology mark-up language (SBML) format. The journal also features:* RSS alerts for instant notification when new papers are published.

Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide- and protein-, oligonucleotide- and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Available in print and online, Molecular Therapy is dedicated to promoting the sciences in genetics, medicine and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy's 2009 impact factor is 6.239*.

methods, technology development, molecular therapy, gene therapy

Molecular Therapy — Nucleic Acids publishes research targeted to the advances in nucleic acid-based therapeutics to treat and/or correct genetic and acquired disease. Subject areas include: development of therapeutics based on nucleic acids and their derivatives, vector development and design for the delivery of RNA-based therapeutics, and applications of gene-modifying agents.

Molecular Vision is a peer-reviewed journal dedicated to the dissemination of research results in molecular biology, cell biology, and the genetics of the visual system (ocular and cortical).Molecular Vision publishes articles presenting original research that has not previously been published and comprehensive articles reviewing the current status of a particular field or topic. Submissions to Molecular Vision are subjected to rigorous peer review. Molecular Vision does NOT publish preprints.

Molecular and Cellular Biochemistry: An International Journal for Chemical Biology in Health and Disease publishes original research papers and short communications in all areas of the biochemical sciences, emphasizing novel findings relevant to the biochemical basis of cellular function and disease processes, as well as the mechanics of action of hormones and chemical agents. Coverage includes membrane transport, receptor mechanism, immune response, secretory processes, and cytoskeletal function, as well as biochemical structure-function relationships in the cell. In addition to the reports of original research, the journal publishes state of the art reviews. Specific subjects covered by Molecular and Cellular Biochemistry include cellular metabolism, cellular pathophysiology, enzymology, ion transport, lipid biochemistry, membrane biochemistry, molecular biology, nuclear structure and function, and protein chemistry.

The German Society of Pediatrics and Adolescent Medicine (DGKJ) are providing financial support to aid any authors who require assistance with the article-processing charge (1750 EUR/ 1375 GBP/ 2150 USD). If you do not have access to a funding source, please request DGKJ sponsorship during the submission process, by entering the code RA-DGKJ-MACP-1118 on the payment page. The sponsorship will cover the full cost of the article-processing charge.

Molecules and Cells is owned and published by the Korean Society for Molecular and Cellular Biology. It is published monthly in a printed and an electronic version. Information about the journal is available online at: http://molcells.org. Its editorial policies are the responsibility of the Editor-in-Chief, the Associate Editors, the Advisory Board, and the Editorial Board under the general authority of the Publications Committee and the Council. Molecules and Cells publishes papers based on original research that are judged, after editorial review, to make a substantial contribution to the understanding of any area of molecular and cellular biology. Manuscripts may be submitted for consideration as Research Articles or Communications. The journal also publishes Minireviews, all of which are by invitation only.

Monash Bioethics Review Monash Bioethics Review provides comprehensive coverage of traditional topics and emerging issues in bioethics. The Journal is especially concerned with empirically-informed philosophical bioethical analysis with policy relevance. Monash Bioethics Review also regularly publishes empirical studies providing explicit ethical analysis and/or with significant ethical or policy implications.  Produced by the Monash University Centre for Human Bioethics since 1981 (originally as Bioethics News), Monash Bioethics Review is the oldest peer reviewed bioethics journal based in Australia--and one of the oldest bioethics journals in the world.